#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	17020	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2195	770.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1443	1443	C	983	C	935	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31038	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3810	813.1	0	.	n	.	0	T695C	SNP	695	695	T	1151	1151	C	900	C,T	849,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31038	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3810	813.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1793	1793	A	1054	A,G	985,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31038	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3810	813.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2427	2427	C	978	C	909	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31038	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3810	813.1	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3053	3053	T	903	T,C	868,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31038	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3810	813.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2501	2501	A	982	A	942	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	V36A	NONSYN	106	108	GTG	487	489	GCG	207;205;204	G;C;G	195;194;196	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	529	531	CGG	202;202;203	C;G;G	198;196;198	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	S68L	NONSYN	202	204	TCG	583	585	TTG	177;178;176	T;T,C;G	158;162,1;168	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	A90V	NONSYN	268	270	GCG	649	651	GTT	169;169;168	G;T,C;T,G	155;153,1;154,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	I105V	NONSYN	313	315	ATT	694	696	GTT	184;184;187	G;T;T	175;166;175	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	N125T	NONSYN	373	375	AAT	754	756	ACC	205;203;202	A;C;C	189;186;187	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	R135C	NONSYN	403	405	CGT	784	786	TGT	201;201;200	T;G;T	180;189;182	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	K151E	NONSYN	451	453	AAA	832	834	GAA	159;161;159	G;A;A	151;154;151	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	T152N	NONSYN	454	456	ACC	835	837	AAC	160;160;159	A;A;C	152;153;152	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	A172T	NONSYN	514	516	GCG	895	897	ACA	139;140;142	A;C;A	134;135;137	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	A175E	NONSYN	523	525	GCG	904	906	GAA	143;145;145	G;A;A	139;142;141	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	E176T	NONSYN	526	528	GAA	907	909	ACC	146;147;146	A;C;C	135;144;142	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	I178V	NONSYN	532	534	ATC	913	915	GTC	145;145;146	G;T;C	139;140;142	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	I188T	NONSYN	562	564	ATA	943	945	ACG	151;154;155	A;C;G,A	143;147;143,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	P200N	NONSYN	598	600	CCC	979	981	AAC	156;153;153	A;A;C	149;147;147	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1039	1041	TTG	158;159;159	T;T;G	145;146;147	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1096	1098	ACC	138;138;139	A;C;C	125;129;131	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1099	1101	GAC	141;143;145	G;A;C	132;128;136	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1108	1110	GCG	145;144;144	G;C;G	136;117;134	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1144	1146	GCT	125;122;123	G;C;T	117;113;111	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1694	folP	858	858	91.61	folP.l6.c30.ctg.1	1566	107.5	1	SNP	p	R230S	1	.	.	688	690	AGC	1069	1071	AGC	164;165;164	A;G;C	157;156;155	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5346	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3509	151.9	1	SNP	p	S91F	0	.	.	271	273	TCC	636	638	TCC	195;196;195	T;C;C	185;187;187	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5346	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3509	151.9	1	SNP	p	D95G	0	.	.	283	285	GAC	648	650	GAC	201;201;203	G;A;C	191;190;190	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5346	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3509	151.9	1	SNP	p	D95N	0	.	.	283	285	GAC	648	650	GAC	201;201;203	G;A;C	191;190;190	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1844	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1375	133.5	1	SNP	p	G45D	1	.	.	133	135	GAC	501	503	GAC	236;237;235	G;A;C	226;224;225	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1002	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1091	91.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5514	parC	2304	2304	100.0	parC.l6.c17.ctg.1	2919	187.6	1	SNP	p	D86N	0	.	.	256	258	GAC	552	554	GAC	223;223;221	G;A;C	213;210;211	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5514	parC	2304	2304	100.0	parC.l6.c17.ctg.1	2919	187.6	1	SNP	p	S87I	0	.	.	259	261	AGT	555	557	AGT	221;217;216	A;GTT,GT;T	211;208,1;200	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5514	parC	2304	2304	100.0	parC.l6.c17.ctg.1	2919	187.6	1	SNP	p	S87W	0	.	.	259	261	AGT	555	557	AGT	221;217;216	A;GTT,GT;T	211;208,1;200	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5514	parC	2304	2304	100.0	parC.l6.c17.ctg.1	2919	187.6	1	SNP	p	S87R	0	.	.	259	261	AGT	555	557	AGT	221;217;216	A;GTT,GT;T	211;208,1;200	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5514	parC	2304	2304	100.0	parC.l6.c17.ctg.1	2919	187.6	1	SNP	p	S88P	0	.	.	262	264	TCC	558	560	TCC	218;217;218	T;C;C	202;207;210	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4666	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2665	174.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1476	1478	GGC	242;239;236	G;G;C	228;224;222	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4364	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2274	190.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1224	1226	GCA	259;256;255	G;C;A	239;236;238	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4364	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2274	190.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1227	1229	ATC	255;254;253	A;T;C	239;237;236	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4364	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2274	190.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1239	1241	GTG	237;236;238	G;T;G	224;223;227	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4364	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2274	190.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1239	1241	GTG	237;236;238	G;T;G	224;223;227	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4364	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2274	190.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1743	1745	ACC	192;192;192	A;C;C	178;178;182	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4364	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2274	190.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1797	1799	GCG	187;188;192	G;C;G	161;150;164	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4364	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2274	190.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1797	1799	GCG	187;188;192	G;C;G	161;150;164	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4364	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2274	190.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1920	1922	GGC	173;173;172	G;G;C	158;155;155	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4364	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2274	190.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1929	1931	GGC	160;158;159	G;G;C	140;135;138	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4364	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2274	190.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1947	1949	CCG	134;135;139	C,G;C;GCCC,GCCCC	105,3;110;112,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	6432	ponA	2397	2397	99.96	ponA.l15.c17.ctg.1	3099	206.7	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1645	1647	CTG	221;227;226	C;T;G	195;201;198	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2446	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1904	127.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	587	587	C	182	C	174	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	G38E	NONSYN	112	114	GGA	530	532	GAA	270;269;265	G;A;A	260;260;256	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	S46G	NONSYN	136	138	AGC	554	556	GGC	264;265;270	G,A;G,A;C,A	251,1;249,1;253,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	E48G	NONSYN	142	144	GAA	560	562	GGA	273;276;276	G;G,A;A	259;259,2;257	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	T87A	NONSYN	259	261	ACT	677	679	GCT	262;262;264	G,A;C;T	234,2;239;233	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	T89S	NONSYN	265	267	ACC	683	685	AGC	259;256;256	A;G,C;C,T	231;234,1;233,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	.	MULTIPLE	358	359	AA	775	776	CG	227;228	C;G	216;215	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	.	MULTIPLE	361	362	GA	778	780	CAG	227;226;226	C;A;G	217;216;215	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	N122K	NONSYN	364	366	AAC	782	784	AAA	222;224;226	A;A,C;A	214;213,1;218	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	K143E	NONSYN	427	429	AAA	845	847	GAA	239;241;239	G;A;A	229;227;228	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	V151A	NONSYN	451	453	GTA	869	871	GCA	249;252;251	G,T;C;A	235,1;241;238	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	A215T	NONSYN	643	645	GCT	1061	1063	ACT	288;286;284	A;C;T	283;279;274	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1070	1072	ATG	284;283;279	A,G;T;G	275,1;278;269	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1184	1186	GCA	251;249;248	G;C;A	238;234;236	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1187	1189	ACG	247;247;249	A;C;G	231;232;236	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	S258G	NONSYN	772	774	AGT	1190	1192	GGG	248;248;246	G;G;G	234;233;232	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1193	1195	GTT	245;247;246	G;T;T	232;228;230	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1253	1255	GTA	273;270;270	G;T;A	255;255;253	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1292	1294	ACT	290;296;293	A;C;T	272;282;277	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1298	1300	GAT	299;295;294	G;A;T	288;282;283	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1310	1312	CAC	287;288;285	C;A;C	276;279;273	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	1	SNP	p	G120K	1	.	.	358	360	AAG	775	777	CGG	227;228;224	C;G;G	216;215;210	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	1	SNP	p	D121N	0	.	.	361	363	GAC	778	781	CGC	227;226;222	C;G;C	217;215;213	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3348	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1607	207.3	1	SNP	p	A121D	1	.	.	361	363	GAC	778	781	CGC	227;226;222	C;G;C	217;215;213	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	12516	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4813	259.2	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1926	1928	CAT	310;309;309	C,A;A;T	296,3;299;297	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1408	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1023	136.0	1	SNP	p	V57M	1	.	.	169	171	ATG	492	494	ATG	275;270;270	A,G;T,C;G	259,1;252,1;250	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
